Skip to content
OpenCapital
Get started

Artelo Biosciences ARTL Q4 2024 Annual earnings

Reported March 3, 2025 · Before market open

EPS-$7.02Miss by $4.40
EPS estimate-$2.62

Next report

Aug 12, 2026 (In 2 weeks)
EPS estimate-$0.72

Versus estimates

Diluted EPS

Q1 2026-$4.00Miss by $3.22Q4 2025-$6.66Miss by $1.95Q3 2025-$3.97Miss by $3.15Q2 2025-$5.61Miss by $1.42Q1 2025-$4.32Miss by $3.52
Q4 2024-$7.02Miss by $4.40

Ask the moment Artelo Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Artelo Biosciences report Q4 2024 earnings?
Artelo Biosciences (ARTL) reported Q4 2024 earnings on March 3, 2025 before market open.
What were Artelo Biosciences's Q4 2024 revenue and EPS?
Artelo Biosciences reported eps of $-7.02 for Q4 2024.
Did Artelo Biosciences beat estimates in Q4 2024?
EPS missed the consensus estimate of $-2.62 by $4.40.
Where can I find Artelo Biosciences's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001640334-25-000335) directly on SEC EDGAR. The filing index links above go to sec.gov.